دورية أكاديمية
COVID-19 during pregnancy and adverse outcomes: Concerns and recommendations from The Brazilian Teratology Information Service.
| العنوان: | COVID-19 during pregnancy and adverse outcomes: Concerns and recommendations from The Brazilian Teratology Information Service. |
|---|---|
| المؤلفون: | Vianna FSL; Universidade Federal do Rio Grande do Sul, Departamento de Genética, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil.; Hospital de Clínicas de Porto Alegre, Sistema Nacional de Informações sobre Agentes Teratogênicos, Porto Alegre, RS, Brazil.; Hospital de Clínicas de Porto Alegre, Laboratório de Medicina Genômica, Serviço de Pesquisa Experimental, Porto Alegre, RS, Brazil.; Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Programa de Pós-Graduação em Ciências Médicas, Porto Alegre, RS, Brazil., Fraga LR; Hospital de Clínicas de Porto Alegre, Sistema Nacional de Informações sobre Agentes Teratogênicos, Porto Alegre, RS, Brazil.; Hospital de Clínicas de Porto Alegre, Laboratório de Medicina Genômica, Serviço de Pesquisa Experimental, Porto Alegre, RS, Brazil.; Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Programa de Pós-Graduação em Ciências Médicas, Porto Alegre, RS, Brazil.; Universidade Federal do Rio Grande do Sul, Instituto de Ciências Básicas da Saúde, Departamento de Ciências Morfológicas, Porto Alegre, RS, Brazil., Abeche AM; Hospital de Clínicas de Porto Alegre, Sistema Nacional de Informações sobre Agentes Teratogênicos, Porto Alegre, RS, Brazil., Silva AAD; Hospital de Clínicas de Porto Alegre, Sistema Nacional de Informações sobre Agentes Teratogênicos, Porto Alegre, RS, Brazil.; Universidade do Vale do Taquari (Univates), Programa de Pós Graduação em Ciências Médicas, Lajeado, RS, Brazil., Sanseverino MTV; Universidade Federal do Rio Grande do Sul, Departamento de Genética, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil.; Hospital de Clínicas de Porto Alegre, Sistema Nacional de Informações sobre Agentes Teratogênicos, Porto Alegre, RS, Brazil., Schuler-Faccini L; Universidade Federal do Rio Grande do Sul, Departamento de Genética, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil.; Hospital de Clínicas de Porto Alegre, Sistema Nacional de Informações sobre Agentes Teratogênicos, Porto Alegre, RS, Brazil. |
| المصدر: | Genetics and molecular biology [Genet Mol Biol] 2021 Mar 10; Vol. 44 (1 Suppl 1), pp. e20200224. Date of Electronic Publication: 2021 Mar 10 (Print Publication: 2021). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Sociedade Brasileira de Genética Country of Publication: Brazil NLM ID: 100883590 Publication Model: eCollection Cited Medium: Print ISSN: 1415-4757 (Print) Linking ISSN: 14154757 NLM ISO Abbreviation: Genet Mol Biol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Ribeirão Preto, SP, Brazil : Sociedade Brasileira de Genética, 1998- |
| مستخلص: | SARS-CoV-2 virus was first identified in the beginning of 2020 and has spread all over the world, causing the Coronavirus Disease 2019 (COVID-19) pandemic. The virus is a member of the Coronavirus family, which includes viruses that cause common cold, Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). MERS and SARS are known by causing adverse events in pregnancy. Considering that SARS-CoV-2 is a new infection agent, little is known about the risk of its infection to human embryo/fetal development. However, SARS and MERS were associated with negative outcomes, such as miscarriage, preterm birth, intrauterine growth restriction and perinatal death. Here, we raise concerns and possibilities related the harmful potential of SARS-CoV-2 and COVID-19 to pregnancy, discussing symptoms, immunological changes during pregnancy, SARS-CoV-2 mutation rate (and the risks related to it). Finally, we point out recommendations to be performed by the scientific community and health care workers in order to identify and to manage potential risks to pregnant women and their babies. |
| References: | BMC Infect Dis. 2020 Aug 3;20(1):564. (PMID: 32746801) J Immunol. 2010 Jul 15;185(2):1248-57. (PMID: 20554966) Int J Environ Res Public Health. 2020 Jun 11;17(11):. (PMID: 32545378) Am J Obstet Gynecol MFM. 2020 May;2(2):100107. (PMID: 32292902) Am J Obstet Gynecol. 2020 Dec;223(6):914.e1-914.e15. (PMID: 32553908) Clin Infect Dis. 2020 Sep 12;71(6):1400-1409. (PMID: 32270184) Ir Med J. 1983 Jul;76(7):320-1. (PMID: 6885332) PLoS One. 2020 Apr 16;15(4):e0230295. (PMID: 32298273) JAMA. 2020 Apr 7;323(13):1239-1242. (PMID: 32091533) MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1641-1647. (PMID: 33151921) Clin Infect Dis. 2020 Nov 19;71(16):2035-2041. (PMID: 32249918) Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:543-558. (PMID: 32713730) Int J Gynaecol Obstet. 2020 Oct;151(1):154-156. (PMID: 32644220) Science. 2020 Aug 7;369(6504):607. (PMID: 32764043) Am J Obstet Gynecol. 1989 Sep;161(3):657-62. (PMID: 2782348) Am J Obstet Gynecol. 2004 Jul;191(1):292-7. (PMID: 15295381) PLoS One. 2014 Feb 18;9(2):e88624. (PMID: 24558404) Reprod Toxicol. 2008 Jan;25(1):120-3. (PMID: 17977696) Am J Reprod Immunol. 2015 Mar;73(3):199-213. (PMID: 25582523) Mol Syst Biol. 2019 Feb 18;15(2):e8503. (PMID: 30777892) Pediatr Dev Pathol. 2020 May-Jun;23(3):177-180. (PMID: 32397896) Endocrinology. 2020 Sep 1;161(9):. (PMID: 32730568) Viruses. 2020 Feb 10;12(2):. (PMID: 32050635) Nature. 2003 Nov 27;426(6965):450-4. (PMID: 14647384) Pediatrics. 2014 Mar;133(3):e674-88. (PMID: 24567014) MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):59-62. (PMID: 26820244) AJR Am J Roentgenol. 2020 Jul;215(1):127-132. (PMID: 32186894) Am J Reprod Immunol. 2010 Jun;63(6):425-33. (PMID: 20367629) J Neurosci. 2007 Oct 3;27(40):10695-702. (PMID: 17913903) Lancet. 2020 Mar 7;395(10226):809-815. (PMID: 32151335) Int J Gynaecol Obstet. 2020 May;149(2):130-136. (PMID: 32196655) Lancet. 2020 May 9;395(10235):1483-1484. (PMID: 32353329) Obstet Gynecol. 2020 Aug;136(2):262-272. (PMID: 32544146) J Virol. 2011 May;85(9):4122-34. (PMID: 21325420) Nat Rev Immunol. 2017 Aug;17(8):469-482. (PMID: 28627518) Science. 2017 Nov 17;358(6365):933-936. (PMID: 28971967) Cell Rep. 2020 Oct 27;33(4):108308. (PMID: 33113372) Am Rev Respir Dis. 1980 Mar;121(3):559-81. (PMID: 6998334) Nat Commun. 2018 Feb 2;9(1):475. (PMID: 29396410) Nature. 2020 May;581(7806):22-26. (PMID: 32367025) Trends Microbiol. 2016 Jun;24(6):490-502. (PMID: 27012512) Am J Clin Pathol. 2020 Jun 8;154(1):23-32. (PMID: 32441303) Clin Infect Dis. 2021 Mar 1;72(5):862-864. (PMID: 32182347) Nat Rev Microbiol. 2016 Aug;14(8):523-34. (PMID: 27344959) Nat Rev Microbiol. 2019 Mar;17(3):181-192. (PMID: 30531947) Am J Obstet Gynecol. 2020 May;222(5):415-426. (PMID: 32105680) Mol Hum Reprod. 2004 Jan;10(1):55-63. (PMID: 14665707) N Engl J Med. 2020 Feb 20;382(8):692-694. (PMID: 31978293) J Virol. 2019 Mar 5;93(6):. (PMID: 30626688) Clin Obstet Gynecol. 1996 Mar;39(1):107-19. (PMID: 8635293) Arch Pathol Lab Med. 2020 Jul 1;144(7):799-805. (PMID: 32180426) Nucleic Acids Res. 2020 Jan 8;48(D1):D77-D83. (PMID: 31665515) Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651) Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. (PMID: 32105090) J Clin Invest. 2017 May 1;127(5):1591-1599. (PMID: 28459427) Pediatrics. 2003 Oct;112(4):e254. (PMID: 14523207) Am J Obstet Gynecol. 2020 Jul;223(1):91.e1-91.e4. (PMID: 32376317) J Reprod Immunol. 2020 Jun;139:103122. (PMID: 32244166) |
| تواريخ الأحداث: | Date Created: 20210312 Latest Revision: 20231111 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC7953204 |
| DOI: | 10.1590/1678-4685-GMB-2020-0224 |
| PMID: | 33710249 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1415-4757 |
|---|---|
| DOI: | 10.1590/1678-4685-GMB-2020-0224 |